v3.10.0.1

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
Sales	$ 1,385,444	$ 1,368,771	$ 4,123,560	$ 3,753,072
Cost of Sales	959,491	889,021	2,732,015	2,344,982
Gross Margin	425,953	479,750	1,391,545	1,408,090
Operating Expenses:
Labor	163,283	204,114	510,959	568,991
Legal and Professional	69,071	53,329	226,558	157,221
General and Administrative	53,409	94,507	161,601	225,553
Rent Office Space and Servers	35,071	63,524	158,799	180,822
Depreciation	38,009	65,996	107,456	197,537
Bad Debt Expense	15,000	8,724	44,021	88,981
Insurance	12,436	10,466	33,301	31,338
Travel	4,127	4,836	22,864	25,894
Management Fees	3,455	5,389	12,859	13,851
Advertising	545	11,088	7,181	34,965
Total Operating Expenses	394,406	521,973	1,285,599	1,525,153
Income (Loss) from Operations	31,547	(42,223)	105,946	(117,063)
Other Income and (Expenses):
Amortization of Debt Discount	(163,036)	(172,689)	(535,449)	(485,699)
Interest & Penalties Expense	(183,712)	(126,534)	(497,390)	(404,914)
Derivative Liability Gains (Losses)	8,119	0	(17,526)	0
Foreign Currency Gains (Losses)	(37,856)	(11,438)	(40,886)	(74,140)
Provision for Income Taxes	0	0	0	0
Other Income	(17)	(964)	1,225	22,266
Total Other Income (Expenses)	(376,502)	(311,625)	(1,090,026)	(942,487)
Loss from continuing operations	(344,955)	(353,848)	(984,080)	(1,059,550)
Loss from discontinued operations, net	14,439	(347,958)	(959,570)	(556,357)
Total Other Comprehensive Income (Loss)	0	0	0	0
Foreign Currency Translation gain (loss)	(42,112)	(12,495)	(8,661)	42,317
Total Comprehensive Loss	$ (372,628)	$ (714,301)	$ (1,952,311)	$ (1,573,590)
Basic and Diluted Loss per Share from continuing operations	$ (0.009)	$ (0.012)	$ (0.028)	$ (0.039)
Basic and Diluted Loss per Share from discontinued operations	0	(0.011)	(0.027)	(0.021)
Basic and Diluted Loss per Share from Consolidated Operations	$ (0.009)	$ (0.021)	$ (0.055)	$ (0.058)
Weighted Average Shares Outstanding - Basic and Diluted	40,136,209	30,532,982	35,601,441	27,048,006

Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 35
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848

MEDICAL IMAGING CORP. 10-Q